Chemed Total Liabilities 2010-2024 | CHE

Chemed total liabilities for the quarter ending June 30, 2024 were $0.528B, a 4.59% decline year-over-year.

  • Chemed total liabilities for 2023 were $0.56B, a 12.91% decline from 2022.
  • Chemed total liabilities for 2022 were $0.643B, a 10.58% decline from 2021.
  • Chemed total liabilities for 2021 were $0.719B, a 34.8% increase from 2020.

Chemed Total Liabilities 2010-2024 | CHE

  • Chemed total liabilities for 2023 were $0.56B, a 12.91% decline from 2022.
  • Chemed total liabilities for 2022 were $0.643B, a 10.58% decline from 2021.
  • Chemed total liabilities for 2021 were $0.719B, a 34.8% increase from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.4B
Quest Diagnostics (DGX)$17.3B
DaVita (DVA)$13.8B
Encompass Health (EHC)$9.2B
Elanco Animal Health (ELAN)$7.1B
Option Care Health (OPCH)$5.3B
RadNet (RDNT)$4.9B
Amedisys (AMED)$3.2B
Astrana Health (ASTH)$2.7B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$2.4B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$1B
Aveanna Healthcare Holdings (AVAH)$1B
Atai Life Sciences (ATAI)$215M
Daxor (DXR)$46M
ATI Physical Therapy (ATIP)$26M
MEDIROM Healthcare Technologies (MRM)$19M
Psychemedics (PMD)$14M
Ontrak (OTRK)$10M
Novo Integrated Sciences (NVOS)$5M
IMAC Holdings (BACK)$2M